BioSpace News Archive

Remote Healthcare Market: Rise in Geriatric Population and Shortage of Healthcare Resources to Drive the Market

Wilmington, Delaware, United States, Transparency Market Research Inc. – Remote healthcare is a telemedicine service that uses a mobile device to constantly monitor a patient’s condition and performance outside a medical facility.

August 10, 2022
·
6 min read
Fast Approval Of Novel Drugs For The Treatment Has Pushed Diabetic Neuropathy Market To Growth By 5.5% CAGR During The Forecast Period.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global diabetic neuropathy market is expected to witness a CAGR of 5.9% during the forecast period

August 10, 2022
·
7 min read
Point Of Care Diagnostics Market Global Industry Analysis, 2031 | Current and Future Trends | Growth Opportunities

Point-of-care or point-of-use diagnostics, sometimes known as bedside testing, has gained increased prominence in analytical testing over the past few years.

August 10, 2022
·
8 min read
Captor Therapeutics Nominates the Molecular Glue CPT-6281 as Drug Candidate to Enter CTA/IND-Enabling Studies for the Treatment of Hepatocellular Carcinoma

Captor Therapeutics S.A. announces that it has selected CPT-6281 as drug candidate for the CT-01 project, which will initially focus on the clinical development of the asset as a TPD treatment against hepatocellular carcinoma.

August 10, 2022
·
3 min read
European Society for Organ Transplantation’s (ESOT) guidelines for desensitization treatment of highly sensitized kidney transplant patients published in Transplant International

Hansa Biopharma AB, ‘Hansa’, pioneer in enzyme technology for rare immunological conditions, welcomes the publication in Transplant International, the official journal of ESOT, of ESOT’s guidelines for desensitization treatment of highly sensitized kidney transplant patients.1

August 10, 2022
·
3 min read
Drug Development

Artios initiates Phase 2 study of Polθ Inhibitor ART4215 in Combination with PARP Inhibitor Talazoparib in BRCA Deficient Breast Cancer

Artios Pharma Limited announces it has initiated a Phase 2 study with ART4215, a small molecule inhibitor of polymerase theta in combination with talazoparib, an oral poly polymerase inhibitor in an expansion study for the treatment of BRCA deficient breast cancer.

August 10, 2022
·
5 min read
Starpharma signs new DEP® agreement with MSD

Australian biotechnology company Starpharma announced it has signed a new DEP® Research Agreement with MSD, the trade name of Merck Sharp & Dohme LLC, Rahway, NJ, USA.

August 10, 2022
·
2 min read
Business

Asieris Appoints Dr. Badrinath Konety to Scientific Advisory Board

Asieris Pharmaceuticals, a global biopharma company specializing in discovering and developing innovative drugs for the treatment of genitourinary tumors and other related diseases, announces Dr. Badrinath Konety has joined Asieris’ Scientific Advisory Board as an advisor.

August 10, 2022
·
3 min read
Business

Immunocore Reports Second Quarter 2022 Financial Results and Provides Business Update

Immunocore Holdings plc today announced its financial results for the second quarter ended June 30, 2022 and provided a business update.

August 10, 2022
·
26 min read
Business

2seventy bio Reports Second Quarter Financial Results and Recent Operational Progress

2seventy bio, Inc. (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, today reported financial results and recent highlights for the second quarter ended June 30, 2022.

August 10, 2022
·
13 min read